✉ Email this page to a colleague
« Back to Dashboard
RG1662 is an investigational drug.
There have been 9 clinical trials for RG1662. The most recent clinical trial was a Phase 2 trial, which was initiated on May 5th 2014.
The most common disease conditions in clinical trials are Down Syndrome, Syndrome, and [disabled in preview]. The leading clinical trial sponsors are Hoffmann-La Roche and [disabled in preview].
There are thirteen US patents protecting this investigational drug and one hundred and sixty-one international patents.
Recent Clinical Trials for RG1662
|A Study of RO5186582 in Down Syndrome Among Children 6 to 11 Years of Age||Hoffmann-La Roche||Phase 2|
|Basmisanil Positron Emission Tomography Study in Japanese Volunteers||Hoffmann-La Roche||Phase 1|
|A Study to Investigate the Effect of CYP3A Inhibition on the Pharmacokinetics of RG1662 in Healthy Subjects||Hoffmann-La Roche||Phase 1|
Top disease conditions for RG1662
Top clinical trial sponsors for RG1662
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|RG1662||See Plans and Pricing||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||See Plans and Pricing|
|RG1662||See Plans and Pricing||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||See Plans and Pricing|
|RG1662||See Plans and Pricing||Compartmented pharmaceutical dosage forms||Triastek, Inc. (Nanjing, CN)||See Plans and Pricing|
|RG1662||See Plans and Pricing||Compositions and methods for neurological diseases||Coda Biotherapeutics, Inc. (South San Francisco, CA)||See Plans and Pricing|
|RG1662||See Plans and Pricing||Isoxazolo-pyridine derivatives||Hoffmann-La Roche Inc (Nutley, NJ)||See Plans and Pricing|
|RG1662||See Plans and Pricing||Process for the preparation of isoxazolyl-methoxy nicotinic acids||Hoffman-La Roche Inc. (Nutley, NJ)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|RG1662||Australia||AU2017261372||2036-05-05||See Plans and Pricing|
|RG1662||Canada||CA3023278||2036-05-05||See Plans and Pricing|
|RG1662||China||CN107847398||2036-05-05||See Plans and Pricing|
|RG1662||European Patent Office||EP3452003||2036-05-05||See Plans and Pricing|
|RG1662||Hong Kong||HK1249728||2036-05-05||See Plans and Pricing|
|RG1662||Japan||JP2019520866||2036-05-05||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|